Jefferies Financial Group’s Collegium Pharmaceutical COLL Stock Holding History

Jefferies Financial Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$992K	Buy	27,400 +3,100	+13%	+$106K	0.01%	973
2026 Q1	$804K	Sell	24,300 -19,940	-45%	-$844K	0.01%	1008
2025 Q4	$2.05M	Sell	44,240 -82,325	-65%	-$3.44M	0.01%	797
2025 Q3	$4.43M	Buy	+126,565	New	+$4.4M	0.02%	394
2024 Q4	–	Sell	-50,000	Closed	-$1.93M	–	1630
2024 Q3	$1.93M	Sell	50,000 -302,000	-86%	-$10.8M	0.01%	608
2024 Q2	$11.3M	Buy	352,000 +311,292	+765%	+$10.8M	0.12%	137
2024 Q1	$1.58M	Buy	+40,708	New	+$1.42M	0.01%	666
2023 Q1	–	Sell	-28,750	Closed	-$667K	–	1681
2022 Q4	$667K	Buy	+28,750	New	+$580K	﹤0.01%	973
2017 Q2	–	Sell	-83,759	Closed	-$843K	–	59
2017 Q1	$843K	Buy	+83,759	New	+$1.25M	0.07%	38

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jefferies Financial Group's COLL Position: Q2 2026 in Review

Jefferies Financial Group increased its Collegium Pharmaceutical (COLL) stake by 13% in Q2 2026, buying an estimated $106K and bringing the position to 27,400 shares worth $992K. The position accounts for 0.01% of the portfolio, ranked #973.

Jefferies Financial Group first reported a position in COLL in Q1 2017 and has held it in 9 quarters since. The position peaked at $11.3M in Q2 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Jefferies Financial Group held 27,400 shares of Collegium Pharmaceutical worth $992K as of Q2 2026.
Jefferies Financial Group bought 3,100 Collegium Pharmaceutical shares in Q2 2026, an estimated $106K.
Collegium Pharmaceutical made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #973 holding.
Jefferies Financial Group first reported a position in Collegium Pharmaceutical in Q1 2017 and has held it in 9 quarters since.
Jefferies Financial Group's Collegium Pharmaceutical position peaked at $11.3M in Q2 2024.
280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.